Cargando…
Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implant...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953003/ https://www.ncbi.nlm.nih.gov/pubmed/31757007 http://dx.doi.org/10.3390/cells8121472 |
_version_ | 1783486550817898496 |
---|---|
author | Perry, Luba Merdler, Uri Elishaev, Maria Levenberg, Shulamit |
author_facet | Perry, Luba Merdler, Uri Elishaev, Maria Levenberg, Shulamit |
author_sort | Perry, Luba |
collection | PubMed |
description | Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implantation in immunocompromised mice. However, the neovascularization and integration processes of transplanted engineered tissues have not been widely studied in immunocompetent models. Here, we fabricated a three-dimensional (3D) vascularized murine muscle construct that was transplanted into immunocompetent and immunocompromised mice. Intravital imaging demonstrated enhanced neovascularization in immunocompetent mice compared to immunocompromised mice, 18 days post-implantation, indicating the advantageous effect of an intact immune system on neovascularization. Moreover, construct prevascularization enhanced neovascularization, integration, and myogenesis in both animal models. These findings demonstrate the superiority of implantation into immunocompetent over immunocompromised mice and, therefore, suggest that using autologous cells might be beneficial compared to allogeneic cells and subsequent immunosuppression. Taken together, these observations have the potential to advance the field of regenerative medicine and tissue engineering, ultimately reducing the need for donor organs and tissues. |
format | Online Article Text |
id | pubmed-6953003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69530032020-01-23 Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice Perry, Luba Merdler, Uri Elishaev, Maria Levenberg, Shulamit Cells Article Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implantation in immunocompromised mice. However, the neovascularization and integration processes of transplanted engineered tissues have not been widely studied in immunocompetent models. Here, we fabricated a three-dimensional (3D) vascularized murine muscle construct that was transplanted into immunocompetent and immunocompromised mice. Intravital imaging demonstrated enhanced neovascularization in immunocompetent mice compared to immunocompromised mice, 18 days post-implantation, indicating the advantageous effect of an intact immune system on neovascularization. Moreover, construct prevascularization enhanced neovascularization, integration, and myogenesis in both animal models. These findings demonstrate the superiority of implantation into immunocompetent over immunocompromised mice and, therefore, suggest that using autologous cells might be beneficial compared to allogeneic cells and subsequent immunosuppression. Taken together, these observations have the potential to advance the field of regenerative medicine and tissue engineering, ultimately reducing the need for donor organs and tissues. MDPI 2019-11-20 /pmc/articles/PMC6953003/ /pubmed/31757007 http://dx.doi.org/10.3390/cells8121472 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Perry, Luba Merdler, Uri Elishaev, Maria Levenberg, Shulamit Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title | Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title_full | Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title_fullStr | Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title_full_unstemmed | Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title_short | Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice |
title_sort | enhanced host neovascularization of prevascularized engineered muscle following transplantation into immunocompetent versus immunocompromised mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953003/ https://www.ncbi.nlm.nih.gov/pubmed/31757007 http://dx.doi.org/10.3390/cells8121472 |
work_keys_str_mv | AT perryluba enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice AT merdleruri enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice AT elishaevmaria enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice AT levenbergshulamit enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice |